| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.82B | +0.9% |
| Cost of Revenue | $1.26B | +27.1% |
| R&D Expense | $507.6M | +38.5% |
| SG&A Expense | $181.6M | +14.4% |
| Operating Income | -$47.8M | -131.9% |
| Interest Expense | $171.9M | +66.6% |
| Pre-tax Income | -$205.2M | -543.0% |
| Income Tax | -$12.2M | -211.5% |
| Net Income | -$192.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.08B | -28.9% |
| Accounts Receivable | $702.8M | +36.6% |
| Current Assets | $1.94B | -40.1% |
| Total Assets | $5.85B | -5.1% |
| Current Liabilities | $579.0M | -9.6% |
| Long-term Debt | $3.21B | -0.5% |
| Total Liabilities | $3.95B | -2.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $412.8M | +14.1% |
| Capital Expenditures | $662K | -52.4% |
| Investing Cash Flow | -$1.37B | -12.9% |
| Financing Cash Flow | -$526.8M | -116.9% |
| Free Cash Flow | $412.1M | +14.3% |
| -643.8% |
| EPS (Basic) | -$0.52 | -620.0% |
| EPS (Diluted) | -$0.52 | -677.8% |
| Stockholders' Equity |
| $1.90B |
| -11.0% |